Vimarsana
Biggest News Aggregation in the World

Clinical Study Group News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Clinical Study Group. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Clinical Study Group Today - Breaking & Trending Today

Management of Clostridoides Difficile: A Focus on the Pharmacist's Role in the Care Continuum - Vimarsana News

Management of Clostridoides Difficile: A Focus on the Pharmacist's Role in the Care Continuum

Published: June 16, 2023

Patient education and counseling play a critical role in preventing C. difficile recurrence, and pharmacists are uniquely positioned to provide treatment recommendations, educate patients and health care providers, optimize transitions of care, and reduce the risk of recurrent CDI.

Source: pharmacytimes.com
Related Topics:
United StatesDavidn DahdalPaul FeuerstadtInfectious Diseases Society Of AmericaCenters For DiseaseC Diff Centers For DiseaseClinical Study GroupIts Negative Impacts On Human HealthGut HealthSociety For Healthcare Epidemiology Of AmericaInfectious Diseases SocietyHealthcare EpidemiologyPharmacist CounselingLaura StongNaomi SacksKathleen LangMedical EconomicsDisease ControlInfect DisClin Infect DisImpact AnalysisFidaxomicin Versus VancomycinInfection RiskImportant Antibiotic ClassesEvent Reporting
Tillotts Pharma AG announces that DIFICLIRTM (fidaxomicin) is recommended for the treatment of Clostridioides difficile infection (CDI) by ESCMID - Vimarsana News

Tillotts Pharma AG announces that DIFICLIRTM (fidaxomicin) is recommended for the treatment of Clostridioides difficile infection (CDI) by ESCMID

Published: December 8, 2021

DIFICLIRTM (fidaxomicin) is now recommended as first-line CDI treatment in both European and U.S. guidelines1,2 Significantly fewer patients in the fidaxomicin group than the vancomycin group

Source: finanznachrichten.de
Related Topics:
United StatesUnited KingdomMark WilcoxKostenloser WertpapierhandelVan PrehnSusi TeichmannTillotts PharmaAdrian HillAntimicrob ChemotherJapanese Zeria GroupClinical Study GroupSociety For Healthcare Epidemiology Of AmericaInfectious Disease Society Of AmericaLeeds Teaching Hospitals University OfHead Of International OperationsCorporate CommunicationsEuropean Society Of Clinical MicrobiologyEuropean Centre For Disease PreventionFirst Section Of Tokyo Stock ExchangeInfectious Diseases Society Of AmericaZeria Pharmaceutical Co LtdEuropean SocietyClinical MicrobiologyInfectious DiseasesInfectious Disease Society